Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Lung Diseases 1

Interventions

Carboplatin 106 pembrolizumab 93 Pemetrexed 80 Cisplatin 68 Specimen Handling 44 Paclitaxel 38 durvalumab 36 Nivolumab 36 Docetaxel 33 Magnetic Resonance Spectroscopy 32 osimertinib 28 atezolizumab 26 Etoposide 22 Gemcitabine 21 Radiotherapy 19 130-nm albumin-bound paclitaxel 18 Cetuximab 16 amivantamab 14 Radiosurgery 14 Radiation 12 Platinum 12 Ipilimumab 12 Bevacizumab 12 lazertinib 11 cemiplimab 11 Taxes 11 Immunoglobulin G 11 Topotecan 10 Ramucirumab 10 Disulfides 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

One-Lung Ventilation × Thoracic × 30 days × Clear all

NCT00534690 2026-05-15

REVOLU

University Hospital, Bordeaux

Phase NA Completed

Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡